Health Management International (HMI)

(Nov 30): After a 91% surge in its share price since 2016, Health Management International has gained an important new supporter – a unit of Singapore’s state investment firm.

SINGAPORE (Nov 16): Maybank Kim Eng is maintaining its “buy” call on Health Management International (HMI) with a target price of 80 cents, after the group’s 1Q18 core earnings came in line with expectations to make up 27% of the research house’s

SINGAPORE (Nov 15): OCBC Investment Research is ceasing coverage on Health Management International (HMI) due to an internal reallocation of its resources.

SINGAPORE (Nov 13): Health Management International reported a more than doubling of  its 1Q18 earnings ended Sept to RM13.8 million ($4.5 million) from RM6.2 million a year ago.

SINGAPORE (Sept 11): UOB Kay Hian is maintaining its “buy” call on Health Management International (HMI) with an unchanged target price of 83 cents.

SINGAPORE (Aug 31): The Edge Singapore last week reported that Health Management International (HMI) is among a clutch of SGX healthcare stocks that has outperformed the Straits Times Index last year.

SINGAPORE (Aug 29): Phillip Capital is maintaining its “buy” recommendation on Health Management International (HMI) at a target price of 83 cents, while expressing a positive view on the group’s FY18 earnings outlook.

SINGAPORE (Aug 28): OCBC Investment Research is maintaining its “buy” recommendation on Health Management International (HMI) with an unchanged fair value estimate of 80 cents.

SINGAPORE (Aug 24): Regional private healthcare provider Health Management International (HMI) reported a 3.5% rise in FY17 earnings to RM20.6 million ($6.5 million) from a year ago.

SINGAPORE (June 19): UOB Kay Hian is remaining “market weight” on Singapore’s healthcare sector on expectations of decelerating medical tourism growth in Singapore, due to rising competition from neighbouring Asean countries such as Malaysia.